US12597516B2 physiotherapy device control, wireless remote

US12597516B2 physiotherapy device control, wireless remote

System and method for automated diagnosis

USPTO granted patent US12597520B2 to Regents of the University of Michigan for an automated diagnosis method. The patent covers a system receiving user data inputs, converting them to stored data, determining severity indexes, predicting medical conditions, and identifying presence/absence of conditions for output. The patent contains 20 claims and is classified under G16H (Health Informatics).

Pressure Ulcer Management System and Computing Device

USPTO granted patent US12597522B2 to Ajou University Industry-Academic Cooperation Foundation covering a method and system for managing pressure ulcers using a computing device with risk evaluation and prevention management modules. The patent includes 17 claims and covers technology for assessing patient pressure ulcer risk levels and scheduling prevention activities in hospital settings.

Predictive health recommendation system using large data models

The USPTO granted Patent US12597526B2 to Included Health Inc. covering systems and methods for generating predictive data models to provide personalized health action recommendations. The patent describes acquiring service requests, identifying user features, segmenting users, generating recommended actions, determining expected values, and ranking outputs. The patent contains 20 claims and falls under CPC classifications G16H 50/70, G16H 10/60, G16H 20/00, and G06N 20/00 (health informatics and machine learning).

Insecticidal proteins from plants and methods for their use - US12595488B2

USPTO granted Patent No. 12,595,488 B2 to Pioneer Hi-Bred International, Inc. covering compositions and methods for producing insecticidal proteins derived from plants. The patent claims 10 protected compositions including nucleic acid sequences, expression vectors, and transformed organisms useful for controlling Lepidopteran, Coleopteran, Dipteran, fungal, Hemipteran, and nematode pest populations.

Sterile genes and related constructs and applications thereof

USPTO granted patent US12595489B2 to SINOBIOWAY BIO-AGRICULTURE GROUP CO. LTD. covering isolated polynucleotides, polypeptides, and recombinant DNA constructs for regulating plant sterility, with 3 claims allowed under CPC classification C12N 15/829. The patent, which issues from application 17597380 filed July 5, 2019, provides intellectual property protection for sterility gene technology in plants.

Rapamycin resistant cells

Seattle Children's Hospital has been granted US Patent 12595492B2 for rapamycin resistant cell compositions and methods. The patent covers proteins expressed in host cells to confer rapamycin resistance, with applications in modulating cell signaling and selective cell expansion. The patent contains 32 claims with six named inventors including Andrew M. Scharenberg and David J. Rawdings.

Roche UBE3A Angelman Syndrome Oligonucleotide Patent Granted

USPTO granted patent US12596118B2 to Hoffmann-La Roche Inc. covering oligonucleotides capable of inducing paternal UBE3A expression for treatment of Angelman syndrome. The patent, listing 9 inventors, contains 30 claims targeting the SNHG14 long non-coding RNA downstream of SNORD109B. This is a pharmaceutical composition patent within the oligonucleotides therapeutic space.

DISARM Therapeutics patent, SARM1 inhibitors, neuroprotection

DISARM Therapeutics patent, SARM1 inhibitors, neuroprotection

Treatment of tumors with miRNA targeting CDK4/CDK6

USPTO granted patent US12595483B2 to the Institute for Cancer Research of Fox Chase Cancer Center for miRNA mimics targeting CDK4 and/or CDK6 for tumor treatment, including colon cancer. The patent covers modified oligonucleotides comprising miRNA and methods for administering the compositions to patients.